Association of tirofiban treatment with outcomes following endovascular therapy in cardioembolic stroke: insights from the RESCUE BT randomized trial.

Eur J Med Res · 2023 · PMC10621173 · PMID 37915101

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Secondly, the tirofiban group exhibited a significantly longer time from symptom onset to randomization, leading to a delayed time to reperfusion, although the difference in the time from symptom onset to reperfusion did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.